Effect of Local Gentamicin Infiltration on Surgical Site Infection Following Lower Limb Open Reduction and Internal Fixation: A Randomized Double-Blinded Trial
Main Article Content
Abstract
Background: Surgical site infection (SSI) remains a formidable complication in orthopedic
surgery, particularly in the presence of implanted biomaterials such as plates and intramedullary
nails. While perioperative antimicrobial prophylaxis is standard practice, local antibiotic
infiltration may offer additional protection against infection in open reduction and internal
fixation procedures.
Objective: To evaluate the additive effect of local gentamicin infiltration on the incidence of
surgical site infection following lower limb open reduction and osteosynthesis.
Methods: This prospective, randomized, double-blind, hospital-based interventional study
enrolled 100 patients indicated for open plating or intramedullary nailing of lower limb fractures
or deformities. Participants were randomized into two groups of 50 each: Group A (control)
received 4 mL of normal saline, and Group B (intervention) received 160 mg gentamicin (4 mL)
infiltrated into the surgical wound prior to closure. Both groups received intravenous ceftriaxone
prophylaxis intraoperative and for 72 hours postoperatively. Wounds were drained, and patients
were followed for 90 days. Wound assessment for infection was performed on days 3, 7, 10, 14,
28, and at 6 and 12 weeks using the ASEPSIS score.
Results: Ninety-three patients completed 90-day follow-up (7 lost to follow-up). The majority
were male (74.2%) and aged 26–35 years (37.6%). Traumatic fracture fixation comprised 83.9%
of cases, with femur (47.7%) and tibia (36.6%) as the most common anatomical sites. Plating
was the predominant fixation method (50.5%). The overall infection rate was 11.8%, with 17.4%
in Group A and 6.4% in Group B; however, the difference was not statistically significant (p =
0.120). Significant risk factors for SSI included BMI >25 kg/m² (p = 0.010), operative duration
>3 hours (p = 0.019), and perioperative blood transfusion (p = 0.001). No association was found
with diabetes, hypertension, or ASA class II status. Staphylococcus aureus was the most
frequently isolated organism.
Conclusion: Local gentamicin infiltration was associated with a lower infection rate compared
with placebo, though the difference did not reach statistical significance. Identified modifiable
risk factors—obesity, prolonged operative time, and blood transfusion—warrant targeted
preventive strategies.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Kisibo A, Ndume VA, Semiono A, Mika E, Sariah A, Protas J. Et al. Surgical site
infection among patients undergone orthopaedic surgery at Muhimbili Orthopaedic
Institute, Dar es Salaam, Tanzania. East cent afr J sur 2017;22(1): 40-58
2. Itai G, Amit J, Norachart S, Elliott H, Erik H. Current practice of antibiotic prophylaxis
for surgical fixation of closed long bone fractures: A review of 297 members of
orthopaedic trauma association. Patient Saf Surg 11;2 (2017).
https://doi.org/10.1186/s13037-016-0118-5
3. Young QX, Yue-Liang Z, Xin-yv F, Tao J, Yang L, Xiao-qing H. Implant- Related
Infection in Tibia: Surgical revision with vancomycin cement. (internet) the Sci world J
2014. DOI. http://dx.doi.org/10.1155/2014/124864
4. Public Health England. Protocol for the surveillance of surgical site infection: Surgical
Site Infection Suveillance Services. Public health England; 2013
5. Borchardt RA, Tzizik D. Update on surgical site infection: the new CDC guidelines
JAAPA 2018; 31:52-54
6. Al-Mulhim FA, Baragbah MA, Sadat-Ali M, Alomran AS, Azam MQ. Prevalence of
surgical site infection in orthopaedic surgery: A 5 years analysis. Int J Surg 2014; 99
(3):264-268
7. Ukpoju E, Sough T, Imam A. The incidence of surgical site infection in orthopaedic
implant surgery: A study of two tartiary hospital in Nigeria. GSJ 2020; 8(1)1792-1801
8. World Health Organization. Antibiotics of choice for surgical antibiotic prophylaxis.
Geneva; WHO Department of service delivery and safety; 2016
9. Kaye JA, Jick H. Epidemiology of lower limb fractures in general practice in the United
Kingdom: Injury prevention. British Med J 2004;10:368-374
10. Pascal C, Eric L, Ireti F, Adebola P, Christian T, Oswald G. et al. Epidemiology of
fractures in tropical countries. Eur Sci J 2017; 13(24): 416-426
11. Palle JN, Asang C, Chichom A, Fokam P, Eleanor G, Ngwayu C. et al. Prevalence and
pattern of lower extremity injuries due to road traffic crashes. Pan Afr Med J. 2019;32:53
12. Yanbin B, Xiong Z, Ye T, Dehu T, Bing Z. Incidence of surgical site infection following
open reduction and internal fixation of a distal femur fracture: An observational
case–control study. Medicine (2019) 98:7
13. De Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site
infection: incidence and impact on hospital utilization and treatment costs. Am J Infect
Control? 2009;37:387
14. Kimberly K Hurley. Management of infected hardware; Bone and joint institute,
Cooper University Hospital. (internet) Pdf access 21 December, 2019
15. Preventing and Managing Infection and other Complication after Orthopaedic trauma. J
Orthop Trauma. 2017; 31(4):6
16. Zyaie A, Saied AR. Prophylactic topical gentamicin after open reduction and internal
fixation of fractures in orthopaedic. J applied Sci. 2008; 8(20):3753-3756
17. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-
fixation devices. Injury. 2006;37 Suppl 2:S59-66.
18. Zimmerli W. Clinical presentation and treatment of orthopaedic implant-associated
infection. J Intern Med. 2014;276(2):111-119.
19. Winkler H, Stoiber A, Kaudela K, et al. Local antibiotic treatment of prosthetic joint
infections: a review of the literature. Arch Orthop Trauma Surg. 2012;132(10):1531-
1539.
20. Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint
infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin
Infect Dis. 2013;56(1):e1-e25.
21. Chiang HY, Herwaldt LA, Blevins AE, Cho E, Schweizer ML. Effectiveness of local
vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J.
2014;14(3):397-407.
22. Metsemakers WJ, Kuehl R, Moriarty TF, et al. Infection after fracture fixation: current
surgical and microbiological concepts. Injury. 2018;49(3):511-522.
23. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep
infection after primary TKA. Clin Orthop Relat Res. 2009;467(6):1577-1581.
24. Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking
and smoking cessation: a systematic review and meta-analysis. Arch Surg.
2012;147(4):373-383.
25. Kabata T, Maeda T, Kajino Y, et al. Obesity combined with low plasma adiponectin level
is associated with increased risk of wound complications following spinal surgery. Spine
J. 2015;15(3):457-465.
26. Proctor LD, Davenport DL, Bernard AC, Zwischenberger JB. General surgical operative
duration is associated with increased risk of surgical site infection. Am Surg.
2010;76(8):796-803.
27. Cheng H, Chen BP, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative
duration increases risk of surgical site infections: a systematic review. Surg Infect
(Larchmt). 2017;18(6):722-735.
28. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and
infection. Arch Pathol Lab Med. 1994;118(4):371-379.
29. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an
update. Blood Rev. 2007;21(6):327-348.
30. Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines from the AABB:
Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025-2035.
31. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis
of blood management in patients having a total hip or knee arthroplasty. J Bone Joint
Surg Am. 1999;81(1):2-10.
32. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee
prostheses for diagnosis of infection. N Engl J Med. 2007;357(7):654-663.
33. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding
empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint
infection managed by debridement, irrigation and prosthesis retention. J Infect.
2007;55(1):1-7.
34. Edmiston CE Jr, Seabrook GR, Johnson CP, et al. Comparative of a novel and
gentamicin-loaded calcium sulphate/hydroxyapatite bone graft substitute: elution kinetics
and antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus
aureus. J Bone Joint Infect. 2017;2(1):6-14.
35. Ogirima FI, Dahiru IL. Surgical site infection following orthopaedic implant surgery in a
tertiary hospital in Nigeria. Niger J Surg Res. 2006;8(1-2):19-22.
36. Akinleye SD, Garofolo G, Culbertson MD, Homel P, Erez O. Surgical site infection in
orthopedic surgery: incidence and risk factors at an academic institution in the Caribbean.
J Orthop. 2019;16:30-34.
37. de Boer AS, Mintjes-de Groot AJ, Severijnen AJ, van den Berg JM, van Pelt W. Risk
assessment for surgical site infections in orthopedic patients. Am J Med Qual.
1999;14(6):352-357.
38. Wilson AP, Treasure T, Sturridge MF, Grüneberg RN. A scoring method (ASEPSIS) for
postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet.
1986;1(8476):311-313.